Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Studies on the disposition of a 5-nitroimidazole in laboratory animals

  • 6 Accesses

  • 1 Citations

Summary

The disposition and metabolism of a 5-nitroimidazole compound (SC 28538) was investigated in the rat, beagle dog and rhesus monkey. The absorption of [14C]-SC 28538 was rapid and essentially complete after oral dosage in male animals, and also after intravaginal dosage in the female rat. Peak plasma levels of radioactivity occurred within 2 h of dosage. In the rat and dog the radioactivity was excreted predominantly in the faeces (> 60%) but in the monkey more than 60% was excreted in the urine. In both the male and pregnant female rat radioactivity was concentrated in the gastro-intestinal tract, liver and harderian gland and the concentrations of radioactivity in other tissues was generally lower than in plasma. Radioactivity was cleared more rapidly from plasma than from the majority of tissues. SC 28538 was extensively metabolised to form glucuronide and amino acid conjugates. The half-life of SC 28538 was of the order of 1 h in the dog and 3.7 h in the monkey.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Tweit, R.C., Kreider, E.M., and Muir, R.D. (1973): Synthesis of antimicrobial nitroimidazolyl 2-sulfides,-sulfoxides and -sulphones. J. Med. Chem.,16, 1161–1169.

  2. 2.

    Tweit, R.C., Muir, R.D. and Ziecina, S. (1977): Nitroimidazoles with antibacterial activity againstNeisseria gonorrhoeae. J. Med. Chem.,20, 1697–1700.

  3. 3.

    Goldstein, E.J.C., Sutter, V.L. and Finegold, S.M. (1978): Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole and SC 28538. Antimicrob. Ag. Chemother.,14, 609–613.

  4. 4.

    Vose, C.W., Stevens, P.M. and Dickens, J.P. (1981): Liquid chromatographic analysis of an antimicrobial 5-nitroimidazolyl-2-sulphide derivative in biological fluids. J. Chromatog. Biomed. Applic.,225, 488–492.

  5. 5.

    Dickens, J.P., Dyer, R.L., Hamill, B.J. et al. (1981): Reassignment of the structure of iodonitroimidazole, its N-methyl derivatives and related compounds. J. Org. Chem.,46, 1781–1786.

  6. 6.

    Upton, R.A. (1975): Simple and reliable method for serial sampling of blood from rats. J. Pharm. Sci.,64, 112–114.

  7. 7.

    Sedman, A.J. and Wagner, J.G. (1974): Autoan, A Decision-Making Pharmacokinetic Computer Program. Publication Distribution Services, Ann Arbor, Michigan.

  8. 8.

    Metzler, C.M. (1969): Technical Report No. 7292/69/7292/005 Upjohn Co., Kalamazoo, Michigan.

  9. 9.

    Wood, B.A., Rycroft, D. and Munro, A.M. (1973): The metabolism of tinidazole in the rat and dog. Xenobiotica,3, 801–812.

  10. 10.

    Ings, R.M.J., McFadzean, J.A. and Ormerod, W.E. (1975): The fate of metronidazole and its implications in chemotherapy. Xenobiotica,3, 223–235.

  11. 11.

    Buttar, H.S., Siddiqui, W.H. and Moffatt, J.H. (1979): The disposition of [14C]-metronidazole in rats following vaginal and oral administration. J. Pharm. Pharmacol.,31, 542–544.

  12. 12.

    Buttar, H.S. and Siddiqui, W.H. (1980): Pharmacokinetics and metabolic disposition of14C-metronidazole derived radioactivity in rat after intravenous and intravaginal administration. Arch. Int. Pharmacol.,245, 4–19.

  13. 13.

    Schwartz, D.E., Jordan, J.C., Vetler, W. and Oesterhalt, G. (1979): Metabolic studies of ornidazole in the rat, the dog and in man. Xenobiotica,9, 571–581.

  14. 14.

    Smith, R.L. (1973): in: The Excretory Function of Bile. Chapman and Hall, London, pp. 76–93.

  15. 15.

    Smith, R.L. and Caldwell, J. (1977): in: Drug Metabolism from Microbes to Man. Taylor & Francis, London, pp. 331–356.

  16. 16.

    Koch, R.L., Chrystal, E.J.T., Beaulieu, B.B. and Goldman P. (1979): Acetamide — a metabolite of metronidazole formed by the intestinal flora. Biochem. Pharmacol.,28, 3611–3615.

  17. 17.

    Koch, R.L. and Goldman, P. (1979): The anaerobic metabolism of metronidazole forms N-(2-hydroxyethyl)-oxamic acid. J. Pharm. Exp. Ther.,208, 406–410.

Download references

Author information

Correspondence to A. Barrow.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Barrow, A., Burford, S.R., Forrest, T.J. et al. Studies on the disposition of a 5-nitroimidazole in laboratory animals. European Journal of Drug Metabolism and Pharmacokinetics 12, 85–90 (1987). https://doi.org/10.1007/BF03189881

Download citation

Key words

  • Nitroimidazole
  • metabolism
  • animals
  • conjugates